ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于变更董事会秘书的公告 | 2025-12-01 | Chinese | |
| 第六届董事会第十四次会议决议公告 | 2025-12-01 | Chinese | |
| 关于全资子公司与专业投资机构共同投资的进展公告 | 2025-11-19 | Chinese | |
| 2025年第二次临时股东会决议公告 | 2025-11-17 | Chinese | |
| 2025年第二次临时股东会法律意见书 | 2025-11-17 | Chinese | |
| 关于公司签署战略合作框架协议的进展公告 | 2025-11-10 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36046684 | 关于变更董事会秘书的公告 | 2025-12-01 | Chinese | ||
| 36046673 | 第六届董事会第十四次会议决议公告 | 2025-12-01 | Chinese | ||
| 36046666 | 关于全资子公司与专业投资机构共同投资的进展公告 | 2025-11-19 | Chinese | ||
| 36046657 | 2025年第二次临时股东会决议公告 | 2025-11-17 | Chinese | ||
| 36046649 | 2025年第二次临时股东会法律意见书 | 2025-11-17 | Chinese | ||
| 36046642 | 关于公司签署战略合作框架协议的进展公告 | 2025-11-10 | Chinese | ||
| 36046632 | 关于续聘会计师事务所的公告 | 2025-10-29 | Chinese | ||
| 36046621 | 关于为子公司增加担保额度的公告 | 2025-10-29 | Chinese | ||
| 36046613 | 第六届董事会第十三次会议决议公告 | 2025-10-29 | Chinese | ||
| 36046601 | 2025年三季度报告 | 2025-10-29 | Chinese | ||
| 36046600 | 关于召开2025年第二次临时股东会的通知 | 2025-10-29 | Chinese | ||
| 36046590 | 关于关联方对全资子公司增资及对外投资设立合资公司暨关联交易的公告 | 2025-10-29 | Chinese | ||
| 36046584 | 信息披露暂缓与豁免管理制度 | 2025-10-29 | Chinese | ||
| 36046576 | 关于睿智医药科技股份有限公司申请向特定对象发行股票的审核问询函之回复报告（豁免版） | 2025-10-13 | Chinese | ||
| 36046522 | 立信会计师事务所（特殊普通合伙）关于睿智医药科技股份有限公司申请向特定对象发行股票的审核问询函回复说明（豁免版） | 2025-10-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.